Ruti Aga's Six-Year Ban: The Forged Prescription That Killed the Only Defence That Could Have Worked

The cleanest forgery of the 2020s in athletics was not written in a doping case file. It was written on a prescription pad. The Athletics Integrity Unit rang the clinic whose name was printed on it. The clinic did not exist. The person whose signature sat at the bottom had no medical registration — he was a family member. Asked where the pad had come from, he said it was an old pad left over from a former workplace. That workplace disowned the pad too. Three verifications, three denials, and one athlete with no remaining defence.

The numbers are the skeleton and they are simple. Ruti Aga, thirty-two, Ethiopian marathon runner, banned for six years. Two for the presence of a prohibited substance, four for tampering with evidence and testimony during the investigation. The ban runs from 10 September, the same date her provisional suspension began. The AIU statement came on Thursday.

I coded the Salt Lake gantry because the sport refused to explain itself. There is no gantry here — only a laboratory report and a prescription. The principle holds: when the game withholds the data, you build the instrument yourself. Here the instrument is a difference between two drug classes and a single date.

Start with the error repeated in almost every report. Methylprednisolone was described as a prohibited steroid and said to be classed as performance-enhancing by WADA. That classification is wrong. Methylprednisolone is a glucocorticoid, class S9 on the WADA Prohibited List — not an anabolic steroid, which is S1. The distinction is not cosmetic. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only by three routes: injection, oral, or rectal.

The consequence is direct: a therapeutic knee injection given during training is entirely legal. It becomes a violation only if residue is present in-competition. This was never a steroid case. It was a route-and-timing case.

The road-race testing window tightens the equation. In-competition testing opens at 23:59 the day before the race. An injection given three or four days out that has not cleared will be caught. The window is not friendly to athletes, and it is designed that way.

Now the real technical centre. What does a competent defence look like? Two paths existed. A Therapeutic Use Exemption: a top marathoner receiving treatment for knee synovitis has records, and those records support an exemption application. Or correct washout timing: an injection placed far enough before the race that residue is zero on race day. Neither happened. A prescription was manufactured instead.

And here is the paradox that makes the sanction look irrational if you skip it: the more medically plausible the explanation, the more damning the forgery. Intra-articular methylprednisolone for knee synovitis is standard sports medicine in distance runners. That plausibility made real records the strongest available defence — and made fabricating them instead an act of self-destruction.

Open the sanction arithmetic. Two years for presence: the standard outcome for a Specified Substance where intent is not proven. Four years for tampering: the Code's standard sanction, not an exceptional escalation. The sum is six and six was entirely predictable.

One thing the arithmetic reveals that no statement spells out: the panel rejected the no-significant-fault mitigation. Had it been granted, the presence sanction could have fallen to months or a formal reprimand. Six tells us the panel found presence proven without intent, and treated the tampering as fully culpable.

A finer point. Forging a document is itself circumstantial evidence of concealment intent. Yet it did not push the presence sanction to four years, which the Code permits. The panel weighed the two violations separately and added them. Technically clean, morally arguable.

Counting the ban from 10 September is no discount. Provisional suspension time is credited against the sanction. That is a procedural benefit, not a reduction. The real sum is this: add six years to thirty-two. Return comes at thirty-eight.

The depth of Ethiopian women's marathon running is the number that makes that age arithmetic final. A generation runs under 2:16; world-record class athletes sit above it; a 2:18 performer is not automatically selectable. A thirty-eight-year-old with a six-year doping record has no place in that selection equation. In practice this is a lifetime ban written as six years.

And one fact that slips past this section and usually goes unsaid: the 2026 Tokyo Marathon title is hers, and the violation attaches to a March race years later. Absent a finding of earlier use, results before that date are not automatically annulled. The disqualification scope is unstated. What is not stated I will not assume — not for her, not against her.

The March result in China and its prize money are almost certainly voided, since disqualification of the competition where the sample was collected is standard AIU practice. That too is unstated. My inference, not a fact.

Now the part that is the actual story and got buried under the headline. The knee injury. That is this case's entry point. Chronic knee pathology is a known failure mode in high-volume marathoners. The pressure to mask pain is equally known, because road-racing income runs on appearance fees, and appearance fees run on form. An athlete not in form does not get invited.

Under that pressure a glucocorticoid is the cheapest, most available tool. And where that tool is available, something else is usually absent — a regular team physician. The medical structure visible here is not a structure at all. A family member, unregistered, writing a prescription in the name of a clinic that does not exist. This is not a clerical slip. It is the signature of an athlete operating without credentialed medical support.

This is what I call the instrumentation gap. Across thirty years of Indian athletics I watched the same shape from the other side — stories default to hero-myth because nobody supplies the data to argue with. East African road running has the opposite problem. The data exists, the testing exists, and precisely for that reason document verification has become the new front where the fight is fought.

The notebook is not a relic; it is my tactical instrument panel. And the pattern filed there says the first violation in AIU road cases is now often lighter than the second — the second buries the first. The substance charge is small; the explanation charge is large.

Discipline is required here. This is one case. One athlete, one March race, one panel, one statement. Declaring a continental trend from it is the same error as building a national conclusion from a single Federation Cup heat sheet. What can be said is bounded: in this case the substance charge lost to the document charge.

The angle least written and most consequential. The substance had no proven endurance benefit. Methylprednisolone reduces inflammation; it does not build muscle, improve oxygen carriage, or extend the fatigue threshold. Yet the sanction is six years. That is not an inconsistency — it is the design. The punishment attaches to the lie, not the drug.

The design is correct. If forging documents carried a light sanction, the first instinct of every athlete would be to forge paper. But the design has a side-effect the sport should own: from outside, the sanction reads as disproportionate to the substance, and both sides will weaponise that reading — one calling it excessive, the other calling it soft.

When the media called the substance a steroid, it widened that gap. Readers assumed an anabolic case. In fact it was a drug entirely legal out-of-competition. The error erased the real technical hinge — route and timing — and left only the number.

One more point I will repeat deliberately. The four years for tampering came from an interview, from answers given under questioning. Language and translation conditions in AIU interviews remain a recurring point of contention, and the question is legitimate here too. It does not change the sanction, because the pad was a physical object. It required no translation.

Sixty-four matches, sixty-four hand-drawn maps, and one stubborn question. The question is the same in every case: where did the system fail? Here the failure is not on the pad. It is in the three months before it. A knee hurt, a race contract was in front of her, there was no team physician, and nobody was there to file the exemption.

I publish what nobody asked for, because the market usually asks the wrong questions. The market is asking whether six years is too much or too little. The right question is who advised her on that prescription. The AIU statement names only the family member. Whether the agent, the manager, the training group were investigated is unmentioned.

Until that is answered, this stays one person's story. And once it becomes one person's story, the lesson dies, because blaming the individual clears the system.

China's label-race circuit is now a high-scrutiny zone. Large appearance fees, deep East African elite fields, AIU testing — all three meet in the same race. The income structure and the testing structure are colliding at exactly the point where medical support is weakest.

Next time a road-race result crosses the desk, look at one thing before the clock: whether the athlete had a credentialed medical document in the weeks around that race. Signatures on prescriptions do not determine six-year bans. The emptiness before the signature does.